Literature DB >> 3079732

Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.

K J Kwon-Chung, J C Rhodes.   

Abstract

Acapsular (Cap-) mutants of Cryptococcus neoformans var. neoformans that produce melanin (Mel+) on diphenol media at 30 degrees C but not at 37 degrees C were found to be avirulent for mice. Compared with wild-type isolates, the mutants had a lower rate of L-3,4-dihydroxyphenylalanine uptake at 37 degrees C and showed an insignificant level of phenoloxidase activity at both temperatures. To study the relationship of Cap and Mel phenotypes to virulence in mice, we crossed one of the mutants (Cap- Mel-) with a wild type (Cap+ Mel+) to obtain four classes of progeny (Cap+ Mel+, Cap+ Mel-, Cap- Mel+, and Cap- Mel-). The progeny with the Cap+ Mel+ phenotype and the wild-type parent (Cap+ Mel+) were inoculated into mice (10(6) cells per mouse) and, within 40 days, produced fatal infection in 90 to 100% of the animals. None of the other three phenotypes produced fatal infection within the same period. While progeny with the Cap+ Mel- phenotype did produce fatal infection after 40 days, 70 to 90% of the mice survived at least until day 70. However, in the isolates recovered from the brain tissue of a mouse that died on day 68, nearly 40% of the CFU had reverted to the Cap+ Mel+ type. The virulence of one of these revertant Cap+ Mel+ isolates was compared with that of a Cap+ Mel- isolate recovered from the same tissue. One hundred percent of the mice inoculated with the revertant died within 35 days, while no fatal infection was produced in the mice inoculated with the Cap+ Mel- isolate within the same period. The isolates with the Cap- Mel+ or Cap- Mel- phenotype not only failed to produce fatal infection but failed to revert to the Cap+ Mel+ type in the mouse brain during the experimental period. These results indicate that both the Cap+ phenotype and the Mel+ phenotype are important indicators of virulence in C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3079732      PMCID: PMC261090          DOI: 10.1128/iai.51.1.218-223.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Recombinational mapping of capsule mutations in Cryptococcus neoformans.

Authors:  C N Still; E S Jacobson
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

2.  Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice.

Authors:  K J Kwon-Chung; I Polacheck; T J Popkin
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

3.  Taxonomic studies on Filobasidiella species and their anamorphs.

Authors:  K J Kwon-Chung; J E Bennett; J C Rhodes
Journal:  Antonie Van Leeuwenhoek       Date:  1982       Impact factor: 2.271

4.  Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans.

Authors:  K J Kwon-Chung
Journal:  Mycologia       Date:  1976 Jul-Aug       Impact factor: 2.696

5.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.

Authors:  T R Kozel; E C Gotschlich
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

6.  Production of diagnostic pigment by phenoloxidase activity of cryptococcus neoformans.

Authors:  C E Shaw; L Kapica
Journal:  Appl Microbiol       Date:  1972-11

7.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

8.  Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans.

Authors:  J C Rhodes; I Polacheck; K J Kwon-Chung
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans.

Authors:  I Polacheck; V J Hearing; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1982-06       Impact factor: 3.490

10.  Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

Authors:  R A Fromtling; H J Shadomy; E S Jacobson
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574

View more
  124 in total

1.  Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans.

Authors:  Y C Chang; K J Kwon-Chung
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

Review 2.  Pathogenic roles for fungal melanins.

Authors:  E S Jacobson
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Cryptococcal Meningitis in HIV-Infected Patients.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

4.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

5.  Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans.

Authors:  Y Wang; P Aisen; A Casadevall
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

6.  The G-protein beta subunit GPB1 is required for mating and haploid fruiting in Cryptococcus neoformans.

Authors:  P Wang; J R Perfect; J Heitman
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

8.  Extraction of high-quality, melanin-free RNA From Mycosphaerella fijiensis for cDNA preparation.

Authors:  Ignacio Islas-Flores; Leticia Peraza-Echeverría; Blondy Canto-Canché; Cecilia Mónica Rodríguez-García
Journal:  Mol Biotechnol       Date:  2006-09       Impact factor: 2.695

9.  Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans.

Authors:  Tiffany Guess; Hoyin Lai; Serenah E Smith; Linda Sircy; Kirsten Cunningham; David E Nelson; Erin E McClelland
Journal:  J Vis Exp       Date:  2018-02-27       Impact factor: 1.355

10.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.